AstraZeneca (AZN) Norway Standardizes On Siebel Pharma (SEBL) To Maximize Sales And Marketing Effectiveness; Leading Pharmaceutical Company Further Aligns Marketing And Sales Business Processes To Strengthen Relationships With Health Care Customers
10/19/2005 5:13:04 PM
BARCELONA, Spain--(BUSINESS WIRE)--April 18, 2005--Siebel Systems, Inc. (Nasdaq:SEBL), the leading provider of customer-facing solutions, today announced that AstraZeneca Norway, a subsidiary of the leading pharmaceutical company, has selected Siebel Pharma to spearhead its program to maximize marketing and sales efficiency and effectiveness. The company will deploy Siebel's industry-specific CRM solution, including Siebel Pharma, Siebel Pharma Field Analytics and Siebel Pharma Marketing, to its sales and marketing professionals to capture and analyze all interactions with more than 15,000 physicians, hospital professionals and pharmacy customers across multiple channels. This integrated customer view will enable AstraZeneca Norway to develop profitable and lasting customer relationships.
"AstraZeneca Norway's continued growth depends on being able to identify, win and retain multiple groups of pharmaceutical customers," said Stephan Pignatel, Head of Strategic Planning and Market Analysis, AstraZeneca Norway. "Siebel Pharma will enable AstraZeneca to enhance the company's sales effectiveness and help develop satisfying and long-term customer relationships. We are impressed by the rich pharmaceutical industry specific functionality, ease of use and robust analytic capabilities of Siebel's solution."
comments powered by